Bouralexis S - Search Results

1

Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.

Evdokiou A, Atkins GJ, Bouralexis S, Hay S, Raggatt LJ, Cowled PA, Graves SE, Clayer M, Findlay DM. Evdokiou A, et al. Among authors: bouralexis s. Int J Oncol. 2001 Sep;19(3):625-32. doi: 10.3892/ijo.19.3.625. Int J Oncol. 2001. PMID: 11494046

2

Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.

Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM. Atkins GJ, et al. Among authors: bouralexis s. J Bone Miner Res. 2000 Apr;15(4):640-9. doi: 10.1359/jbmr.2000.15.4.640. J Bone Miner Res. 2000. PMID: 10780856 Free article.

3

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.

Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM. Atkins GJ, et al. Among authors: bouralexis s. Bone. 2001 Apr;28(4):370-7. doi: 10.1016/s8756-3282(01)00404-5. Bone. 2001. PMID: 11336917

4

Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin.

Bouralexis S, Clayer M, Atkins GJ, Labrinidis A, Hay S, Graves S, Findlay DM, Evdokiou A. Bouralexis S, et al. Int J Oncol. 2004 May;24(5):1263-70. doi: 10.3892/ijo.24.5.1263. Int J Oncol. 2004. PMID: 15067350

5

Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis.

Atkins GJ, Bouralexis S, Evdokiou A, Hay S, Labrinidis A, Zannettino AC, Haynes DR, Findlay DM. Atkins GJ, et al. Among authors: bouralexis s. Bone. 2002 Oct;31(4):448-56. doi: 10.1016/s8756-3282(02)00858-x. Bone. 2002. PMID: 12398939

6

Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism.

Findlay DM, Raggatt LJ, Bouralexis S, Hay S, Atkins GJ, Evdokiou A. Findlay DM, et al. Among authors: bouralexis s. J Endocrinol. 2002 Dec;175(3):715-25. doi: 10.1677/joe.0.1750715. J Endocrinol. 2002. PMID: 12475382

7

Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy.

Bouralexis S, Findlay DM, Atkins GJ, Labrinidis A, Hay S, Evdokiou A. Bouralexis S, et al. Br J Cancer. 2003 Jul 7;89(1):206-14. doi: 10.1038/sj.bjc.6601021. Br J Cancer. 2003. PMID: 12838325 Free PMC article.

8

Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis.

Evdokiou A, Labrinidis A, Bouralexis S, Hay S, Findlay DM. Evdokiou A, et al. Among authors: bouralexis s. Bone. 2003 Aug;33(2):216-28. doi: 10.1016/s8756-3282(03)00223-0. Bone. 2003. PMID: 14499355

9

Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL.

Clayer M, Bouralexis S, Evdokiou A, Hay S, Atkins GJ, Findlay DM. Clayer M, et al. Among authors: bouralexis s. J Orthop Surg (Hong Kong). 2001 Dec;9(2):19-22. doi: 10.1177/230949900100900205. J Orthop Surg (Hong Kong). 2001. PMID: 12118126 Free article.

10

Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.

Thai le M, Labrinidis A, Hay S, Liapis V, Bouralexis S, Welldon K, Coventry BJ, Findlay DM, Evdokiou A. Thai le M, et al. Among authors: bouralexis s. Cancer Res. 2006 May 15;66(10):5363-70. doi: 10.1158/0008-5472.CAN-05-4386. Cancer Res. 2006. PMID: 16707463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters